A new hope in the treatment of onychogryphosis due to acquired malalignment of great toenails: intramatrix dexpanthenol injection.

J Dermatolog Treat

Department of Dermatology and Venereology, Haydarpaşa Numune Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.

Published: December 2023

Download full-text PDF

Source
http://dx.doi.org/10.1080/09546634.2023.2187658DOI Listing

Publication Analysis

Top Keywords

hope treatment
4
treatment onychogryphosis
4
onychogryphosis acquired
4
acquired malalignment
4
malalignment great
4
great toenails
4
toenails intramatrix
4
intramatrix dexpanthenol
4
dexpanthenol injection
4
hope
1

Similar Publications

Expert Opinion on Multiple Myeloma Treatment in Brazil in the Bispecific Antibody Era.

Clin Lymphoma Myeloma Leuk

December 2024

Universidade Federal do Rio de Janeiro -UFRJ, Rio de Janeiro, Brazil; Instituto Americas de Ensino, Pesquisa e Inovação, Rio de Janeiro, Brazil.

Multiple myeloma treatment has evolved rapidly with the development of novel targeted therapies. The paper outlines multiple myeloma epidemiology, current treatments, and recent advances, highlighting the role of bispecific antibodies. Brazilian authorities have approved 3 bispecific antibodies (teclistamab, elranatamab, and talquetamab) for relapsed/refractory multiple myeloma patients who have received at least three prior therapies.

View Article and Find Full Text PDF

This article provides an overview of treatment approaches for chronic kidney disease (CKD) in patients with IgA nephropathy (IgAN). IgAN is the most common primary glomerulonephritis and results from an autoimmune reaction to aberrantly glycosylated immunoglobulin A (IgA) antibodies. Although historically considered largely benign, it is now recognized that a significant percentage of patients develop dialysis-dependent kidney disease over the years.

View Article and Find Full Text PDF

Programmed cell death in nasopharyngeal carcinoma: Mechanisms and therapeutic targets.

Biochim Biophys Acta Rev Cancer

January 2025

Department of Otolaryngology Head and Neck Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China. Electronic address:

Programmed cell death is a type of autonomic and orderly cell death mode controlled by genes that maintain homeostasis and growth. Tumor is a typical manifestation of an imbalance in environmental homeostasis in the human body. Currently, several tumor treatments are designed to trigger the death of tumor cells.

View Article and Find Full Text PDF

The objective was to determine the research status and hotspots of seasonal affective disorders (SAD) based on bibliometric tools, which will contribute to the further research in this field. We used bibliometric tools CiteSpace and VOSviewer to conduct visual quantitative analysis on 465 SAD literatures in the Web of Science core database from 2008 to 2023 from multiple perspectives such as collaboration network, keywords, and literature citations. At the same time, we used Microsoft Word to make relevant tables.

View Article and Find Full Text PDF

Methodological Considerations When Studying Resistance-Trained Populations: Ideas for Using Control Groups.

J Strength Cond Res

December 2024

Department of Health, Exercise Science, and Recreation Management, Kevser Ermin Applied Physiology Laboratory, The University of Mississippi, University, Mississippi; and.

Hammert, WB, Dankel, SJ, Kataoka, R, Yamada, Y, Kassiano, W, Song, JS, and Loenneke, JP. Methodological considerations when studying resistance-trained populations: Ideas for using control groups. J Strength Cond Res 38(12): 2164-2171, 2024-The applicability of training effects from experimental research depends on the ability to quantify the degree of measurement error accurately over time, which can be accounted for by including a time-matched nonexercise control group.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!